Pfizer Shakes Up R&D Leadership, Streamlining Oncology Ahead Of Seagen Merger
Executive Summary
Chief development officer William Pao will depart the company in a sudden transition after being recruited from Roche. Pfizer insiders Chris Boshoff and Mikael Dolsten will fill the roles.